Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 8
Dr. Reddy's Laboratories Limited Snapshot 9
Dr. Reddy's Laboratories Limited Overview 9
Key Information 9
Key Facts 9
Dr. Reddy's Laboratories Limited – Research and Development Overview 10
Key Therapeutic Areas 10
Dr. Reddy's Laboratories Limited – Pipeline Review 12
Pipeline Products by Stage of Development 12
Pipeline Products – Monotherapy 13
Dr. Reddy's Laboratories Limited – Pipeline Products Glance 14
Dr. Reddy's Laboratories Limited – Late Stage Pipeline 14
Phase III Products/Combination Treatment Modalities 14
Dr. Reddy's Laboratories Limited Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Dr. Reddy's Laboratories Limited – Drug Profiles 16
DFA-02 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
DRL 17822 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
DRL-NAB-P2 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Empov 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Dr. Reddy's Laboratories Limited – Pipeline Analysis 20
Dr. Reddy's Laboratories Limited – Pipeline Products by Therapeutic Class 20
Dr. Reddy's Laboratories Limited – Pipeline Products By Target 21
Dr. Reddy's Laboratories Limited – Pipeline Products by Route of Administration 22
Dr. Reddy's Laboratories Limited – Pipeline Products By Mechanism of Action 23
Dr. Reddy's Laboratories Limited – Recent Pipeline Updates 24
Dr. Reddy's Laboratories Limited - Dormant Projects 25
Dr. Reddy's Laboratories Limited - Discontinued Pipeline Products 26
Discontinued Pipeline Product Profiles 26
Balaglitazone 26
DRL 11605 26
DRL 12424 26
DRL 16536 27
RUS 3108 27
Dr. Reddy's Laboratories Limited – Company Statement 28
Dr. Reddy's Laboratories Limited – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Dr. Reddy's Laboratories Limited, Recent Developments 33
Dr. Reddy's Laboratories Limited- Press Release 33
Apr 24, 2012: Dr. Reddy’s Launches Olanzapine Tablets 33
Mar 28, 2012: Dr Reddy’s Launches Quetiapine Fumarate Tablets 33
Mar 03, 2012: Dr. Reddy's Launches Ziprasidone Hydrochloride Capsules 33
Feb 21, 2012: Ranbaxy Launches Atorvastatin In Australia 33
Feb 06, 2012: Alchemia Provides Update On Sales Performance Of Fondaparinux 34
Jan 27, 2012: Dr. Reddy’s Clarifies Media Reports On Issue Pertaining To Promotional Material For Fondaparinux Sodium 34
Oct 06, 2009: Dr. Reddy’s Launches Strea A15 In India 34
Oct 06, 2009: Dr. Reddy’s Launches Strea C10 In India 35
Sep 14, 2009: Dr Reddy’s launches nateglinide generic for diabetes in US 35
Aug 13, 2009: Reddy’s Launches Strea Professional In India 35
Aug 05, 2009: Dr. Reddy’s Launches FINRID In India 36
Jul 30, 2009: Reddy’s Launches Execare In India 36
Jul 01, 2009: Dr Reddy`s receives tentative approval from the USFDA for Valacyclovir Hydrochloride tablets 36
Jun 23, 2009: Dr Reddy’s Launches Bispec In India 36
Jun 09, 2009: Dr. Reddy’s Receives ANDA Approval For Omeprazole Mg OTC From FDA 37
May 21, 2009: Dr. Reddy’s Starts Human Study On DRL 17822 For Dyslipidemia 37
Apr 28, 2009: Dr. Reddy’s Launches Nexret In India 38
Apr 22, 2009: Dr. Reddy’s Launches Redispar In India 38
Feb 05, 2009: Dr. Reddy’s announces multiple ANDA approvals and Generic product launches in the US Market 38
Feb 05, 2009: Dr. Reddy’s Launches Divalproex Capsules And Delayed Release Pellets In US 39
Feb 05, 2009: Dr. Reddy’s Launches Lamotragine CD Chewable Tablets In US 39
Feb 05, 2009: Dr. Reddy’s Launches Lamotragine Tablets In US For Treatment Of Epilepsy And Bipolar Disorder 39
Feb 05, 2009: Dr. Reddy’s Launches Levetiracetam Tablets In US 40
Feb 05, 2009: Dr. Reddy’s Launches Omeprazole Capsules In US 40
Financial Deals Landscape 41
Dr. Reddy's Laboratories Limited, Deals Summary 41
Dr. Reddy's Laboratories Limited, Pharmaceuticals & Healthcare, Deal Details 46
Asset Transactions 46
Dr. Reddy’s Labs Completes Acquisition Of Oral Penicillin Facility And Product Portfolio From GlaxoSmithKline 46
GlaxoSmithKline Acquires Certain Assets Of Dr. Reddy’s 49
Dow Chemical Sells Its Dowpharma Small Molecules Business 50
Dr. Reddy’s Acquires Contract Manufacturing Business From BASF 52
Reddy Pharma Acquires Assets From Laboratorios Litaphar 54
Dr. Reddy's Labs Acquires Three Off-Patent Products From PDL Biopharma 55
Dr. Reddy’s Labs Acquires API Business From Roche 57
Venture Financing 59
Perlecan Pharma Raises $52.5 Million 59
Private Equity 61
3i Group And Clarat Partners Acquire Betapharm Arzneimittel 61
Partnerships 63
Dr. Reddy's Labs Enters Into An Agreement With The Medical House 63
Fujifilm To Form Joint Venture With Dr Reddy's 64
Oceana Therapeutics Enters Into Distribution Agreement With Dr. Reddy’s Labs For Deflux 66
Argenta Discovery Enters Into Collaboration With Dr. Reddy’s Labs 67
SoluBest Enters Into Collaboration With Dr. Reddy's Labs 68
Aurigene Enters Into Research Agreement With Pcovery 69
Alchemia Expands Co-Marketing Agreement With Dr Reddy's Labs 70
GlaxoSmithKline Enters Into Co-Marketing Agreement With Dr. Reddy's Labs 71
Natco Pharma Enters Into Agreement With Dr Reddy's Labs 72
Endo Pharma Partners With Aurigene Discovery Technologies 73
Dr. Reddy's Enters Into Co-Marketing Agreement With Schering And Sepracor 74
Antares Pharma Enters Into Agreement With Dr. Reddy's Labs 75
Dr. Reddy's Labs Signs An Agreement With Albemarle 76
Dr. Reddy's Labs Signs An Agreement With 7TM Pharma 77
Ceragenix Enters Into Distribution Agreement With Dr. Reddy's 78
Laboratorios SALVAT Enters Into Co-Marketing Agreement With Dr. Reddy’s Labs 79
Aurigene Discovery Enters Into Drug Discovery Collaboration With Orion 80
Aurigene Discovery Enters Into Collaboration Agreement With Merck Serono 82
Forest Labs Enters Into An Agreement With Aurigene Discovery 83
Dr. Reddy’s Enters Into Agreement With Torrent Pharma 84
Dr. Reddy's Labs Enters Into An Agreement With ClinTec International 85
Debiopharm Enters Into Co-Development Agreement With Aurigene 87
Dr. Reddy's Labs Enters Into An Agreement With Argenta Discovery 88
Merck & Co. Signs An Agreement With Dr. Reddy's Labs 90
Dr. Reddy's Labs Enters Into An Agreement With Rheoscience 91
Aurigene Discovery Enters Into Research Agreement With Novo Nordisk 93
Dr. Reddy’s Labs Enters Into Agreement With Pharmascience 94
Dr. Reddy's Enters Into Agreement With I-VEN 95
Dr. Reddy's Enters Into Joint Venture To Form APR 96
Licensing Agreements 97
Aegis Therapeutics Enters Into Licensing Agreement With Dr. Reddy's Labs 97
Aquapharm Enters Into Licensing Agreement With Dr. Reddy's Labs 98
Torrent Pharma Enters Into Licensing Agreement With Dr. Reddy's Labs 99
IsoRay Enters Into Licensing Agreement With Dr. Reddy’s Labs For Iotrex 100
Debiopharm Enters Into Option Licensing Agreement With Aurigene Discovery Technologies For Debio 1142 101
Dr. Reddy’s Labs Enters Into Licensing Agreement With R-Pharm 103
Dr. Reddy's Labs Enters Into Licensing Agreement With Cipla 104
Dr Reddy's Labs Enters Into Licensing Agreement With Vitabiotics 105
Transgene Biotek Enters Into Licensing Agreement With Dr Reddy's Labs 106
Dr. Reddy's Labs Enters Into Licensing Agreement With Cymbiotics For DIAPERESE 108
Debiopharm Enters Into Licensing Agreement With Aurigene 109
Cosmederm Technologies Enters Into An Agreement With Dr. Reddy's Labs 111
Dr. Reddy's Labs Enter Into Licensing Agreement With SCOLR Pharma 112
Sinclair Pharma Enters Into Licensing Agreement With Dr. Reddy’s Labs 113
Alchemia Enters Into Licensing Agreement With Dr Reddy's Labs 114
NovaMed Pharma Enters Into Licensing Agreement With Dr. Reddy's 115
Foamix Enters Into Licensing Agreement With Dr. Reddy's Labs 116
Panacea Biotech Enters Into Licensing Agreement with Dr. Reddy’s Labs 117
SkyePharma Enters Into Licensing Agreement With Trigenesis Therapeutics 118
Equity Offering 119
Dr. Reddy's Labs Completes Public Offering Of $229 Million 119
Asset Transactions 121
Watson Pharma Acquires Solid Dosage Manufacturing Facility From Dr. Reddy's Labs 121
Acquisition 123
Dr. Reddy's Labs Acquires Stake In Perlecan Pharma From Citigroup, ICICI And IDBI 123
Dr. Reddy’s Acquires Jet Generici 125
Dr. Reddy's Labs Acquires Betapharm Arzneimittel From 3i Group And Clarat Partners 126
Dr. Reddy’s Labs Acquires Industrias Quimicas Falcon de Mexico From Roche 128
Dr. Reddy's Sells Biomed To KT&T 130
Dr. Reddy's Labs Acquires Trigenesis Therapeutics 131
Reddy Antilles Acquires Remaining 10.2% Stake In Reddy US Therapeutics 132
Appendix 133
Methodology 133
Coverage 133
Secondary Research 133
Primary Research 133
Expert Panel Validation 133
Contact Us 134
Disclaimer 134

List of Tables
List of Tables
Dr. Reddy's Laboratories Limited, Key Information 9
Dr. Reddy's Laboratories Limited, Key Facts 9
Dr. Reddy's Laboratories Limited – Pipeline by Indication, 2012 11
Dr. Reddy's Laboratories Limited – Pipeline by Stage of Development, 2012 12
Dr. Reddy's Laboratories Limited – Monotherapy Products in Pipeline, 2012 13
Dr. Reddy's Laboratories Limited – Phase III, 2012 14
Dr. Reddy's Laboratories Limited – Phase II, 2012 15
Dr. Reddy's Laboratories Limited – Pipeline By Therapeutic Class, 2012 20
Dr. Reddy's Laboratories Limited - Pipeline By Target, 2012 21
Dr. Reddy's Laboratories Limited – Pipeline By Route of Administration, 2012 22
Dr. Reddy's Laboratories Limited – Pipeline Products By Mechanism of Action, 2012 23
Dr. Reddy's Laboratories Limited – Recent Pipeline Updates, 2012 24
Dr. Reddy's Laboratories Limited - Dormant Developmental Projects,2012 25
Dr. Reddy's Laboratories Limited - Discontinued Pipeline Products, 2012 26
Dr. Reddy's Laboratories Limited, Other Locations 30
Dr. Reddy's Laboratories Limited, Subsidiaries 30
Dr. Reddy's Laboratories Limited, Deals Summary 41
Dr. Reddy’s Labs Completes Acquisition Of Oral Penicillin Facility And Product Portfolio From GlaxoSmithKline 46
GlaxoSmithKline Acquires Certain Assets Of Dr. Reddy’s 49
Dow Chemical Sells Its Dowpharma Small Molecules Business 50
Dr. Reddy’s Acquires Contract Manufacturing Business From BASF 52
Reddy Pharma Acquires Assets From Laboratorios Litaphar 54
Dr. Reddy's Labs Acquires Three Off-Patent Products From PDL Biopharma 55
Dr. Reddy’s Labs Acquires API Business From Roche 57
Perlecan Pharma Raises $52.5 Million 59
3i Group And Clarat Partners Acquire Betapharm Arzneimittel 61
Dr. Reddy's Labs Enters Into An Agreement With The Medical House 63
Fujifilm To Form Joint Venture With Dr Reddy's 64
Oceana Therapeutics Enters Into Distribution Agreement With Dr. Reddy’s Labs For Deflux 66
Argenta Discovery Enters Into Collaboration With Dr. Reddy’s Labs 67
SoluBest Enters Into Collaboration With Dr. Reddy's Labs 68
Aurigene Enters Into Research Agreement With Pcovery 69
Alchemia Expands Co-Marketing Agreement With Dr Reddy's Labs 70
GlaxoSmithKline Enters Into Co-Marketing Agreement With Dr. Reddy's Labs 71
Natco Pharma Enters Into Agreement With Dr Reddy's Labs 72
Endo Pharma Partners With Aurigene Discovery Technologies 73
Dr. Reddy's Enters Into Co-Marketing Agreement With Schering And Sepracor 74
Antares Pharma Enters Into Agreement With Dr. Reddy's Labs 75
Dr. Reddy's Labs Signs An Agreement With Albemarle 76
Dr. Reddy's Labs Signs An Agreement With 7TM Pharma 77
Ceragenix Enters Into Distribution Agreement With Dr. Reddy's 78
Laboratorios SALVAT Enters Into Co-Marketing Agreement With Dr. Reddy’s Labs 79
Aurigene Discovery Enters Into Drug Discovery Collaboration With Orion 80
Aurigene Discovery Enters Into Collaboration Agreement With Merck Serono 82
Forest Labs Enters Into An Agreement With Aurigene Discovery 83
Dr. Reddy’s Enters Into Agreement With Torrent Pharma 84
Dr. Reddy's Labs Enters Into An Agreement With ClinTec International 85
Debiopharm Enters Into Co-Development Agreement With Aurigene 87
Dr. Reddy's Labs Enters Into An Agreement With Argenta Discovery 88
Merck & Co. Signs An Agreement With Dr. Reddy's Labs 90
Dr. Reddy's Labs Enters Into An Agreement With Rheoscience 91
Aurigene Discovery Enters Into Research Agreement With Novo Nordisk 93
Dr. Reddy’s Labs Enters Into Agreement With Pharmascience 94
Dr. Reddy's Enters Into Agreement With I-VEN 95
Dr. Reddy's Enters Into Joint Venture To Form APR 96
Aegis Therapeutics Enters Into Licensing Agreement With Dr. Reddy's Labs 97
Aquapharm Enters Into Licensing Agreement With Dr. Reddy's Labs 98
Torrent Pharma Enters Into Licensing Agreement With Dr. Reddy's Labs 99
IsoRay Enters Into Licensing Agreement With Dr. Reddy’s Labs For Iotrex 100
Debiopharm Enters Into Option Licensing Agreement With Aurigene Discovery Technologies For Debio 1142 101
Dr. Reddy’s Labs Enters Into Licensing Agreement With R-Pharm 103
Dr. Reddy's Labs Enters Into Licensing Agreement With Cipla 104
Dr Reddy's Labs Enters Into Licensing Agreement With Vitabiotics 105
Transgene Biotek Enters Into Licensing Agreement With Dr Reddy's Labs 106
Dr. Reddy's Labs Enters Into Licensing Agreement With Cymbiotics For DIAPERESE 108
Debiopharm Enters Into Licensing Agreement With Aurigene 109
Cosmederm Technologies Enters Into An Agreement With Dr. Reddy's Labs 111
Dr. Reddy's Labs Enter Into Licensing Agreement With SCOLR Pharma 112
Sinclair Pharma Enters Into Licensing Agreement With Dr. Reddy’s Labs 113
Alchemia Enters Into Licensing Agreement With Dr Reddy's Labs 114
NovaMed Pharma Enters Into Licensing Agreement With Dr. Reddy's 115
Foamix Enters Into Licensing Agreement With Dr. Reddy's Labs 116
Panacea Biotech Enters Into Licensing Agreement with Dr. Reddy’s Labs 117
SkyePharma Enters Into Licensing Agreement With Trigenesis Therapeutics 118
Dr. Reddy's Labs Completes Public Offering Of $229 Million 119
Watson Pharma Acquires Solid Dosage Manufacturing Facility From Dr. Reddy's Labs 121
Dr. Reddy's Labs Acquires Stake In Perlecan Pharma From Citigroup, ICICI And IDBI 123
Dr. Reddy’s Acquires Jet Generici 125
Dr. Reddy's Labs Acquires Betapharm Arzneimittel From 3i Group And Clarat Partners 126
Dr. Reddy’s Labs Acquires Industrias Quimicas Falcon de Mexico From Roche 128
Dr. Reddy's Sells Biomed To KT&T 130
Dr. Reddy's Labs Acquires Trigenesis Therapeutics 131
Reddy Antilles Acquires Remaining 10.2% Stake In Reddy US Therapeutics 132

List of Figures
List of Figures
Dr. Reddy's Laboratories Limited – Pipeline by Indication, 2012 11
Dr. Reddy's Laboratories Limited – Pipeline by Stage of Development, 2012 12
Dr. Reddy's Laboratories Limited – Monotherapy Products in Pipeline, 2012 13
Dr. Reddy's Laboratories Limited – Pipeline By Therapeutic Class, 2012 20
Dr. Reddy's Laboratories Limited - Pipeline By Target, 2012 21
Dr. Reddy's Laboratories Limited - Pipeline Products By Mechanism of Action, 2012 23